Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

TROP-04 - Renforcement de la recommandation de vaccination contre le virus de l'hépatite A (VHA) par un appel téléphonique avant le départ chez des voyageurs ayant une sérologie VHA igG négative prescrite en centre de vaccination internationale (CVI).

Ouattara E, Méchain M, Receveur MC, Duvignaud A, Gabillard D, Malvy D, Pistone T.

Med Mal Infect. 2016 Jun;46(4 Suppl 1):104. doi: 10.1016/S0399-077X(16)30512-1. French. No abstract available.

PMID:
27495648
2.

COL 7-04 - Morbi-mortalité associée au voyage chez des migrants VIH+ originaires d'Afrique tropicale ayant séjourné au pays d'origine.

Pistone T, Abgrall S, Ouattara E, Lele N, Gabillard D, Malvy D, Bouchaud O.

Med Mal Infect. 2016 Jun;46(4 Suppl 1):16. doi: 10.1016/S0399-077X(16)30289-X. French. No abstract available.

PMID:
27495425
3.

Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.

Dahourou DL, Amorissani-Folquet M, Coulibaly M, Avit-Edi D, Meda N, Timite-Konan M, Arendt V, Ye D, Amani-Bosse C, Salamon R, Lepage P, Leroy V; Monod Anrs 12206 Study Group.

J Int AIDS Soc. 2016 Mar 23;19(1):20601. doi: 10.7448/IAS.19.1.20601. eCollection 2016.

4.

Early antiretroviral therapy initiation in west Africa has no adverse social consequences: a 24-month prospective study.

Jean K, Niangoran S, Danel C, Moh R, Kouamé GM, Badjé A, Gabillard D, Eholié S, Dray-Spira R, Lert F, Anglaret X, Desgrées-Du-LoÛ A.

AIDS. 2016 Jun 19;30(10):1677-82. doi: 10.1097/QAD.0000000000001100.

PMID:
27003034
5.

Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.

Ouattara EN, Robine M, Eholié SP, MacLean RL, Moh R, Losina E, Gabillard D, Paltiel AD, Danel C, Walensky RP, Anglaret X, Freedberg KA.

Clin Infect Dis. 2016 Jun 1;62(11):1454-62. doi: 10.1093/cid/ciw117. Epub 2016 Mar 1.

PMID:
26936666
6.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.

Guehi C, Badjé A, Gabillard D, Ouattara E, Koulé SO, Moh R, Ekouevi D, Ahibo H, N'Takpé JB, Menan GK, Deschamps N, Lecarrou J, Eholié S, Anglaret X, Danel C.

AIDS Res Ther. 2016 Feb 25;13:12. doi: 10.1186/s12981-016-0094-y. eCollection 2016.

7.

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.

Ndawinz JD, Anglaret X, Delaporte E, Koulla-Shiro S, Gabillard D, Minga A, Costagliola D, Supervie V.

Bull World Health Organ. 2015 Aug 1;93(8):521-8. doi: 10.2471/BLT.14.147892. Epub 2015 Jun 1.

8.

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.

Boyd A, Maylin S, Moh R, Mahjoub N, Gabillard D, Eholié SP, Danel C, Anglaret X, Zoulim F, Girard PM, Delaugerre C, Lacombefor K; ANRS 12240 VarBVA study.

J Gastroenterol Hepatol. 2016 Mar;31(3):634-44. doi: 10.1111/jgh.13156.

PMID:
26313291
9.

Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification.

Boyd A, Maylin S, Moh R, Gabillard D, Menan H, Mahjoub N, Danel C, Anglaret X, Eholié SP, Girard PM, Zoulim F, Delaugerre C, Lacombe K; ANRS 12240 VarBVA study.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):248-51. doi: 10.1016/j.diagmicrobio.2015.07.009. Epub 2015 Jul 18.

PMID:
26283522
10.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

11.

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.

Boyd A, Moh R, Gabillard D, le Carrou J, Danel C, Anglaret X, Eholié SP, Maylin S, Delaugerre C, Zoulim F, Girard PM, Lacombe K; ANRS 12240 VarBVA study.

Antivir Ther. 2015;20(6):643-54. doi: 10.3851/IMP2959. Epub 2015 Apr 8.

PMID:
25852125
12.

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso.

Coulibaly M, Meda N, Yonaba C, Ouedraogo S, Congo M, Barry M, Thio E, Siribié I, Koueta F, Ye D, Kam L, Blanche S, Van De Perre P, Leroy V; MONOD Study Group ANRS 12206.

PLoS One. 2014 Oct 31;9(10):e111240. doi: 10.1371/journal.pone.0111240. eCollection 2014.

13.

Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.

Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X.

PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.

14.

Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24-month prospective study in Côte d'Ivoire.

Jean K, Gabillard D, Moh R, Danel C, Desgrées-du-Loû A, N'takpe JB, Le Carrou J, Badjé A, Eholié S, Lert F, Anglaret X, Dray-Spira R.

J Int AIDS Soc. 2014 Jun 30;17:18977. doi: 10.7448/IAS.17.1.18977. eCollection 2014.

15.

WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?

Kouamé G, Danel C, Moh R, Badjé A, Jean K, N'takpe JB, Gabillard D, Le Carrou J, du Loû AD, Deschamps N, Eholie S, Anglaret X.

AIDS. 2014 Jun 19;28(10):1533-5. doi: 10.1097/QAD.0000000000000296.

PMID:
24804862
16.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group.

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627. Epub 2013 Sep 27.

17.

Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d'Ivoire.

Jean K, Gabillard D, Moh R, Danel C, Fassassi R, Desgrées-du-Loû A, Eholié S, Lert F, Anglaret X, Dray-Spira R.

J Infect Dis. 2014 Feb 1;209(3):431-40. doi: 10.1093/infdis/jit470. Epub 2013 Aug 29.

18.

Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.

Messou E, Chaix ML, Gabillard D, Yapo V, Toni TD, Minga A, Kouakou MG, Ouattara E, Rouzioux C, Danel C, Eholie SP, Anglaret X.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):211-9. doi: 10.1097/QAI.0b013e3182a009e4.

19.

Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.

Ouattara E, Danel C, Moh R, Gabillard D, Peytavin G, Konan R, Carrou JL, Bohoussou F, Eholie SP, Anglaret X.

J Int AIDS Soc. 2013 Apr 30;16:18059. doi: 10.7448/IAS.16.1.18059.

20.

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.

Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, Etard JF, Pagnaroat M, Fournier-Nicolle I, Eholié S, Konate I, Minga A, Mpoudi-Ngole E, Koulla-Shiro S, Zannou DM, Anglaret X, Laurent C; ANRS 12222 Morbidity Mortality Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):555-61. doi: 10.1097/QAI.0b013e3182821821.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk